CONSIDERATION & UNDERSTANDING

PRESENTATION & DIAGNOSIS

TREATMENT SELECTION

DISEASE MANAGEMENT

20%

52% of patients

don’t take the medicine they are prescribed

$637Bin lost worldwide industry

revenue due to patient non-adherence

STA

RT

What motivators and emotions are driving individuals to seek diagnosis and care before they become a patient? What sources of support, treatment or referral mechanisms are patients exploring prior to clinical diagnosis?

Which features are most prominent in determining treatment compliance and noncompliance? What engagement approaches do patients and caregivers really desire?

Which external forces drive treatment and provider selection? How do patients learn, monitor, evaluate and select potential substitutes or alternatives?

OUTCOMES

86% of patients expect

integrated healthcare from the

life sciences industry

GO

How can I assure clinical, economic and QOL value of my therapy? What are the motivators of adherence? Which habits can I influence to promote compliance? What are the significant patterns regarding treatment usage and health care choice?

5% of all Google

searches are for health-related

information

AWARENESS & RECOGNITION

64% of patients are

willing to provide personal data in

exchange for free information and support services

Which information sources are patients consulting to self-diagnosis? What is their experience? How do emotions play a role in decision making and actions prior to seeking care?

of drug marketing budgets are allocated to after-launch patient engagement

Which factors and forces most matter in shaping choices of care, providers, therapies, technologies and services?

EMBRACING THE MODERN PATIENT TREATMENT JOURNEY

Today’s patients are proactive members in their healthcare journey. And their decision making is not linear - it’s complex, irrational and subject to bias. Even prior to diagnosis, patients are utilizing social media, online communities, blogs, forums and mobile apps to help them understand, diagnose and manage their illness. The age of the digitally-aware patient has arrived, but with it comes a deluge of unconnected and unstructured data, events and records against which conventional “big data” analytics approaches stand little chance towards revealing the many “whys” surrounding choice and behavior. Instead, the military-proven concepts of signals intelligence uncovers a deeper understanding of the patient treatment journey, as well as the relative opportunity within each critical stage, to drive increased outcomes.

Signals Analytics (www.signals-analytics.com) transforms the world’s unconnected data into real time actionable insights to enhance therapeutic e�ectiveness, drive peak revenue and propel patient-centered innovation. By utilizing our augmented intelligence and decision science platform, future achievement is no longer purely within the realm of science and technology, but extends to "beyond the pill" services and integrated care models that drive adherence.